Payment overview · 2025
General Payments
$13.56
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Lee Quinlan, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · MEXICO, MO · NPI 1134122906
Verified facts
What the public records show
CMS Open Payments records show Michael Lee Quinlan, M.D. received $13.56 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 193 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $13.56 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.56 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $13.56 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
193 | 29 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 892 | 186 |
| Amlodipine Besylate | Amlodipine Besylate | 802 | 162 |
| Atorvastatin Calcium | Atorvastatin Calcium | 788 | 184 |
| Pantoprazole Sodium | Pantoprazole Sodium | 579 | 117 |
| Omeprazole | Omeprazole | 575 | 128 |
| Lisinopril | Lisinopril | 562 | 128 |
| Furosemide | Furosemide | 559 | 123 |
| Losartan Potassium | Losartan Potassium | 544 | 106 |
| Gabapentin | Gabapentin | 512 | 102 |
| Potassium Chloride | Potassium Chloride | 471 | 107 |
| Hydrochlorothiazide | Hydrochlorothiazide | 465 | 116 |
| Tamsulosin Hcl | Tamsulosin Hcl | 449 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 342 | 82 |
| Metoprolol Tartrate | Metoprolol Tartrate | 300 | 54 |
| Quetiapine Fumarate | Quetiapine Fumarate | 295 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 290 | 66 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 287 | 70 |
| Duloxetine Hcl | Duloxetine Hcl | 285 | 57 |
| Mirtazapine | Mirtazapine | 273 | 52 |
| Alprazolam | Alprazolam | 272 | 42 |
| Eliquis | Apixaban | 269 | 42 |
| Trazodone Hcl | Trazodone Hcl | 257 | 51 |
| Simvastatin | Simvastatin | 255 | 67 |
| Sertraline Hcl | Sertraline Hcl | 253 | 43 |
| Meloxicam | Meloxicam | 249 | 69 |
| Tramadol Hcl | Tramadol Hcl | 243 | 55 |
| Metformin Hcl Er | Metformin Hcl | 240 | 71 |
| Carvedilol | Carvedilol | 229 | 53 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 227 | 43 |
| Montelukast Sodium | Montelukast Sodium | 225 | 56 |
| Buspirone Hcl | Buspirone Hcl | 223 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 219 | 41 |
| Lorazepam | Lorazepam | 218 | 35 |
| Glipizide Er | Glipizide | 196 | 39 |
| Farxiga | Dapagliflozin Propanediol | 193 | 29 |
| Clonazepam | Clonazepam | 190 | 33 |
| Prednisone | Prednisone | 186 | 110 |
| Allopurinol | Allopurinol | 177 | 45 |
| Famotidine | Famotidine | 170 | 44 |
| Glimepiride | Glimepiride | 161 | 40 |
| Pravastatin Sodium | Pravastatin Sodium | 160 | 39 |
| Ropinirole Hcl | Ropinirole Hcl | 157 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 149 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 148 | 31 |
| Celecoxib | Celecoxib | 147 | 37 |
| Metformin Hcl | Metformin Hcl | 146 | 38 |
| Warfarin Sodium | Warfarin Sodium | 146 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 144 | 30 |
| Donepezil Hcl | Donepezil Hcl | 144 | 20 |
| Finasteride | Finasteride | 138 | 30 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 134 | 133 |
| Pregabalin | Pregabalin | 127 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 125 | 23 |
| Spironolactone | Spironolactone | 121 | 30 |
| Tizanidine Hcl | Tizanidine Hcl | 115 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 115 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 114 | 32 |
| Bupropion Xl | Bupropion Hcl | 111 | 28 |
| Januvia | Sitagliptin Phosphate | 111 | 16 |
| Atenolol | Atenolol | 109 | 21 |
| Baclofen | Baclofen | 108 | 32 |
| Jardiance | Empagliflozin | 107 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 97 | 58 |
| Fluticasone Propionate | Fluticasone Propionate | 93 | 26 |
| Lovastatin | Lovastatin | 91 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 90 | 16 |
| Rexulti | Brexpiprazole | 84 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 82 | 19 |
| Enalapril Maleate | Enalapril Maleate | 82 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 81 | 11 |
| Lamotrigine | Lamotrigine | 80 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 78 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 76 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 73 | 18 |
| Xarelto | Rivaroxaban | 73 | suppressed |
| Topiramate | Topiramate | 72 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 70 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 70 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 69 | 18 |
| Estradiol | Estradiol | 68 | 13 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 67 | 67 |
| Ozempic | Semaglutide | 67 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 66 | 19 |
| Benazepril Hcl | Benazepril Hcl | 65 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 65 | 15 |
| Memantine Hcl | Memantine Hcl | 63 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 63 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 62 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 61 | suppressed |
| Sotalol | Sotalol Hcl | 61 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 60 | 17 |
| Glipizide | Glipizide | 57 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 57 | 41 |
| Primidone | Primidone | 57 | suppressed |
| Aripiprazole | Aripiprazole | 55 | 14 |
| Synthroid | Levothyroxine Sodium | 55 | 16 |
| Cephalexin | Cephalexin | 54 | 27 |
| Ezetimibe | Ezetimibe | 52 | 17 |
| Ondansetron Odt | Ondansetron | 52 | 31 |
| Mounjaro | Tirzepatide | 49 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 49 | 16 |
| Lansoprazole | Lansoprazole | 48 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 48 | 12 |
| Midodrine Hcl | Midodrine Hcl | 48 | 11 |
| Azithromycin | Azithromycin | 47 | 40 |
| Nabumetone | Nabumetone | 47 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 47 | 11 |
| Torsemide | Torsemide | 47 | 12 |
| Labetalol Hcl | Labetalol Hcl | 46 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 46 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 45 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 45 | suppressed |
| Methylprednisolone | Methylprednisolone | 45 | 40 |
| Testosterone Cypionate | Testosterone Cypionate | 45 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 44 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 44 | 13 |
| Levetiracetam | Levetiracetam | 42 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 32 |
| Bupropion Hcl Sr | Bupropion Hcl | 41 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 40 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 39 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 38 | 12 |
| Olanzapine | Olanzapine | 38 | suppressed |
| Fluconazole | Fluconazole | 37 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 16 |
| Propranolol Hcl Er | Propranolol Hcl | 37 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 36 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | suppressed |
| Acyclovir | Acyclovir | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 35 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 27 |
| Diazepam | Diazepam | 33 | suppressed |
| Nyamyc | Nystatin | 32 | 17 |
| Valsartan | Valsartan | 32 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 30 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 29 | suppressed |
| Nifedipine Er | Nifedipine | 28 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 26 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 25 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Naproxen | Naproxen | 24 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 24 | suppressed |
| Irbesartan | Irbesartan | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 15 |
| Mupirocin | Mupirocin | 23 | 11 |
| Rybelsus | Semaglutide | 23 | suppressed |
| Sucralfate | Sucralfate | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 23 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 22 | suppressed |
| Nystatin | Nystatin | 22 | 15 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Xifaxan | Rifaximin | 22 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 20 | suppressed |
| Nystop | Nystatin | 20 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 20 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 14 |
| Anastrozole | Anastrozole | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 14 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 18 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Modafinil | Modafinil | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 14 |
| Paliperidone Er | Paliperidone | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Cefdinir | Cefdinir | 16 | 14 |
| Cefuroxime | Cefuroxime Axetil | 16 | 14 |
| Cilostazol | Cilostazol | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 14 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Felodipine Er | Felodipine | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Ingrezza | Valbenazine Tosylate | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 12 |
| Moxifloxacin | Moxifloxacin Hcl | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Techlite Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Briviact | Brivaracetam | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Leflunomide | Leflunomide | 12 | suppressed |
| Misoprostol | Misoprostol | 12 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Victoza 3-Pak | Liraglutide | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 11 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.56 · 1 records | AstraZeneca Pharmaceuticals LP | BREZTRI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error